FDA Inspection
Emcure Pharmaceuticals LimitedEmcure Pharmaceuticals Limited – FDA Inspection, Apr 5, 2024
Record Details
This FDA Inspection record concerns Emcure Pharmaceuticals Limited, with an inspection on April 5, 2024, issued by the Center for Drug Evaluation and Research, covering drugs.
View Company Profile
ID · de109873-2180-4e01-8947-7c120c1fd2b0
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 1235038
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
FDA Citations
1- 21 CFR 211.160(b)(4)Establishment of calibration procedures
Full citation text and observation details available on the Dashboard.
Other FDA inspections of Emcure Pharmaceuticals Limited
5| Date | Classification | Office | Project area |
|---|---|---|---|
| May 15, 2026 | Not classified | Office of Inspections and Investigations | Drug Quality Assurance |
| July 8, 2025 | Not classified | Office of Inspections and Investigations | |
| February 16, 2023 | VAI | Office of Inspections and Investigations | |
| March 17, 2020 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| February 1, 2019 | Not classified | Office of Inspections and Investigations |
Other documents for Emcure Pharmaceuticals Limited
- FDA Inspection 1317132 - 2026-05-15
- FDA Inspection 1278622 - 2025-07-08
- FDA Inspection 1198647 - 2023-02-16
- FDA Inspection 1140812 - 2020-03-17
- FDA Inspection 1082800 - 2019-02-01
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.